Cargando…
British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy
Currently, there is no guideline to support the use of immunoglobulin replacement therapy (IgRT) in primary and secondary immunodeficiency disorders in UK. The UK Primary Immunodeficiency Network (UK-PIN) and the British Society of Immunology (BSI) joined forces to address this need. Given the pauci...
Autores principales: | Grigoriadou, S, Clubbe, R, Garcez, T, Huissoon, A, Grosse-Kreul, D, Jolles, S, Henderson, K, Edmonds, J, Lowe, D, Bethune, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585546/ https://www.ncbi.nlm.nih.gov/pubmed/35924867 http://dx.doi.org/10.1093/cei/uxac070 |
Ejemplares similares
-
British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non‐infectious complications of common variable immunodeficiency disorders
por: Bethune, C., et al.
Publicado: (2019) -
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
por: Shields, Adrian M, et al.
Publicado: (2022) -
Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig(®)) in the treatment of patients with primary immunodeficiencies
por: Kobayashi, Roger H, et al.
Publicado: (2022) -
COVID-19 infection and vaccination in immunodeficiency
por: Piano Mortari, Eva, et al.
Publicado: (2022) -
Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
por: Turner, P. J., et al.
Publicado: (2019)